Control of Macrophage Activation and Function by PPARs

被引:430
作者
Chawla, Ajay [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA
关键词
inflammation; insulin resistance; atherosclerosis; diabetes; PPARs; alternatively activated macrophages; NITRIC-OXIDE SYNTHASE-2; ALTERNATIVE ACTIVATION; APOPTOTIC CELLS; FATTY-ACIDS; NEGATIVE REGULATOR; NUCLEAR RECEPTORS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; INSULIN SENSITIVITY; INTERFERON-GAMMA;
D O I
10.1161/CIRCRESAHA.110.216523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophages, a key component of the innate defense against pathogens, participate in the initiation and resolution of inflammation, and in the maintenance of tissues. These diverse and at times antithetical functions of macrophages are executed via distinct activation states, ranging from classical to alternative to deactivation. Because the dysregulation of macrophage activation is pathogenically linked to various metabolic, inflammatory and immune disorders, regulatory proteins controlling macrophage activation have emerged as important new therapeutic targets. Here, the mechanisms by which peroxisome proliferator-activated receptors (PPARs) transcriptionally regulate macrophage activation in health and disease states, including obesity, insulin resistance and cardiovascular disease, are reviewed. (Circ Res. 2010;106:1559-1569.)
引用
收藏
页码:1559 / 1569
页数:11
相关论文
共 113 条
[31]   Monocyte and macrophage heterogeneity [J].
Gordon, S ;
Taylor, PR .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (12) :953-964
[32]   Alternative activation of macrophages [J].
Gordon, S .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) :23-35
[33]   MACROPHAGES IN TISSUES AND INVITRO [J].
GORDON, S ;
FRASER, I ;
NATH, D ;
HUGHES, D ;
CLARKE, S .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (01) :25-32
[34]   Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3 [J].
Gratchev, A ;
Guillot, P ;
Hakiy, N ;
Politz, O ;
Orfanos, CE ;
Schledzewski, K ;
Goerdt, S .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 53 (04) :386-392
[35]   Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of L-arginine metabolism [J].
Hesse, M ;
Modolell, M ;
La Flamme, AC ;
Schito, M ;
Fuentes, JM ;
Cheever, AW ;
Pearce, EJ ;
Wynn, TA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6533-6544
[36]   Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones [J].
Hevener, Andrea L. ;
Olefsky, Jerrold M. ;
Reichart, Donna ;
Nguyen, M. T. Audrey ;
Bandyopadyhay, Gautarn ;
Leung, Ho-Yin ;
Watt, Matthew J. ;
Benner, Chris ;
Febbraio, Mark A. ;
Nguyen, Anh-Khoi ;
Folian, Brian ;
Subramaniam, Shankar ;
Gonzalez, Frank J. ;
Glass, Christopher K. ;
Ricote, Mercedes .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (06) :1658-1669
[37]   Inflammation and metabolic disorders [J].
Hotamisligil, Goekhan S. .
NATURE, 2006, 444 (7121) :860-867
[38]   Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase [J].
Huang, JT ;
Welch, JS ;
Ricote, M ;
Binder, CJ ;
Willson, TM ;
Kelly, C ;
Witztum, JL ;
Funk, CD ;
Conrad, D ;
Glass, CK .
NATURE, 1999, 400 (6742) :378-382
[39]  
ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
[40]   PPAR-γ agonists inhibit production of monocyte inflammatory cytokines [J].
Jiang, CY ;
Ting, AT ;
Seed, B .
NATURE, 1998, 391 (6662) :82-86